Impact of DSM-5 and COVID-19 on ADHD Diagnosis Trends in Under 30s

Overview

This study analyzed two decades of ADHD diagnosis data in British Columbia, revealing increased incidence rates associated with DSM-5 implementation and the COVID-19 pandemic. Notably, postpandemic ADHD diagnoses surged among female adolescents and young adults, surpassing males in these groups for the first time.

Background

Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder primarily studied through prevalence rather than incidence. Changes in diagnostic criteria with DSM-5 and the COVID-19 pandemic may have influenced ADHD diagnosis trends, but their impact on incidence rates remains unclear. This study used linked administrative health data from British Columbia to examine temporal changes in ADHD diagnosis rates among individuals aged 3 to 29 years, stratified by age and sex.

Data Highlights

Key Findings

• ADHD diagnosis incidence increased steadily from 2003 to 2012 prior to DSM-5 implementation.
• Post-DSM-5 (2014-2019), incidence accelerated among elementary and high school-aged males and females, with males showing larger increases.
• Following the COVID-19 pandemic (2021-2023), the largest immediate incidence increases occurred in high school-aged and young adult females, surpassing males for the first time.
• Trend accelerations post-pandemic were most pronounced among elementary school-aged males and females, with annual increases of 23.7 and 20.2 per 10,000 respectively.
• DSM-5 revisions emphasizing functional interference may have broadened diagnostic criteria, contributing to increased identification.
• Pandemic-related stressors likely intensified symptoms and facilitated recognition of previously unmet ADHD needs, especially in females.

Clinical Implications

Clinicians should be aware of the rising ADHD diagnosis rates, particularly among female adolescents and young adults post-pandemic, which may reflect increased symptom recognition and help-seeking. Diagnostic criteria changes and social stressors highlight the need for vigilant assessment and tailored service planning to address evolving demographic patterns. Monitoring age- and sex-specific trends is essential for optimizing ADHD care delivery.

Conclusion

ADHD diagnosis incidence in British Columbia increased over two decades, with notable accelerations following DSM-5 implementation and the COVID-19 pandemic. The pronounced postpandemic rise among females underscores the importance of ongoing surveillance and responsive clinical strategies.

References

1. Polanczyk et al. 2015 -- ADHD prevalence and diagnosis
2. American Psychiatric Association 2013 -- DSM-5 Diagnostic Criteria
3. Rommelse et al. 2022 -- COVID-19 impact on ADHD symptoms
4. Faraone et al. 2021 -- ADHD incidence vs prevalence
5. Wang et al. 2019 -- Validated ADHD diagnosis algorithm
6. Kujala et al. 2023 -- ADHD trends in Finland during COVID-19